Fig 1.
Flow chart of the Temprano trial, (N = 2056).
Table 1.
Baseline characteristics for patients included in Temprano trial; N = 2056.
Fig 2.
Changes in prevalence of different CV risk factors according to sex in patients with available data at M0 and M30, Temprano trial (N = 1724).
* High waist circumference: ≥88 cm in women and ≥102 cm in men. **TC: total cholesterol. *** Low HDL-c: High density lipoprotein cholesterol, <1.2 mmol/l in women and <1 mmol/l in men. ****Smoker is defined as an individual who smokes at least one cigarette per day. BMI: body mass index; HBP: high blood pressure; HDL-c: high density lipoprotein cholesterol; P: p-value of Chi 2 test.
Fig 3.
Agreement between the Framingham equations using lipids and BMI; Temprano trial (N = 1422).
Table 2.
Evolution of the CV risk score with Framingham equation (with lipids) between M0 and M30.
Proportional odds cumulative logit model, N = 1422*.
Table 3.
Evolution of the CV risk score with Framingham equation using BMI between M0 and M30.
Proportional odds cumulative logit model, N = 1700.